Utility of Procalcitonin as a Biomarker for Sepsis in Children

Применение прокальцитонина в качестве биомаркера сепсиса у детей
Scott L. Weiss, Kevin J. Downes, Julie C. Fitzgerald
2020-04-27

antibiotic decision-makingpediatric sepsisprocalcitoninrisk stratificationsepsis biomarkers
Sepsis is a complex process defined as life-threatening organ dysfunction caused by a dysregulated host response to infection. It is associated with significant morbidity and mortality rates in both adults and children, and emphasis has been placed on its early recognition and prompt provision of antimicrobials. Owing to limitations of current diagnostic tests (i.e., poor sensitivity and delayed results), significant research has been conducted to identify sepsis biomarkers. Ideally, a biomarker could reliably and rapidly distinguish bacterial infection from other, noninfectious causes of systemic inflammatory illness. In doing so, a sepsis biomarker could be used for earlier identification of sepsis, risk stratification/prognostication, and/or guidance of antibiotic decision-making. In this minireview, we review one of the most common clinically used sepsis biomarkers, procalcitonin, and its roles in sepsis management in these three areas. We highlight key findings in the adult literature but focus the bulk of this review on pediatric sepsis. The challenges and limitations of procalcitonin measurement in sepsis are also discussed.
1
Evidence from adult studies is summarized, but the review primarily evaluates procalcitonin’s utility in pediatric sepsis.
2
Procalcitonin is reviewed as a clinically used biomarker for pediatric sepsis, with potential roles in early identification, risk stratification, and antibiotic decision-making.
3
The ideal sepsis biomarker would rapidly and reliably distinguish bacterial infection from noninfectious causes of systemic inflammatory illness, addressing limitations of current diagnostic tests.
4
The review emphasizes challenges and limitations that affect the interpretation and clinical application of procalcitonin measurements in sepsis.

Procalcitonin as a sepsis biomarker in children with suspected or confirmed sepsis

The utility, diagnostic discrimination, prognostic value, and antibiotic-guidance roles of procalcitonin measurement in pediatric sepsis

Publication Details
Publication Date
2020-04-27
Journal
Publisher
ISSN
Cited by
114
Access Type
Author Information
Authors
Scott L. Weiss
Kevin J. Downes
Julie C. Fitzgerald
Explore further
Open the scid.ai AI chat with a ready-made request: it will find papers on a similar topic and help build a literature review.
Find similar papers in the chat →
Make a presentation
100%